Bentley Systems Brings Infrastructure Digital Twins to NVIDIA Omniverse
12.4.2021 20:00:00 EEST | Business Wire | Press release
GTC21 – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that it is developing applications using the NVIDIA Omniverse platform for photorealistic, real-time visualization and simulation of digital twins of massive-scale industrial and civil infrastructure projects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005214/en/
Image courtesy of Houston Waterworks Team (a Joint Venture of Jacobs Engineering Group, Inc. and CDM Constructors, Inc.)
Bentley Systems has extended the Bentley iTwin platform to integrate with NVIDIA Omniverse to provide a graphics pipeline for AI-enhanced, real-time visualization, and simulation of infrastructure digital twins. This integration allows engineering-grade, millimeter-accurate digital content to be visualized with photorealistic lighting and environmental effects on multiple devices including web browsers, workstations, tablets, and virtual reality and augmented reality headsets from anywhere in the world.
Bentley iTwin is an open, scalable cloud platform that enables engineering firms and owner-operators to create, visualize, and analyze digital twins of infrastructure assets. Digital information managers use it to incorporate engineering data created by diverse design tools into a living digital twin and align it with reality data, IoT data, and other associated data without disrupting their current tools or processes.
Bentley Systems CEO Greg Bentley said, “Visualization and simulation underpin many of the use cases for infrastructure digital twins. The collaboration of Bentley iTwin and NVIDIA Omniverse is delivering real-time, immersive 3D/4D experiences that will enable true-to-reality, physics-based simulation of even the largest and most complex infrastructure assets. GPU-computing is transforming the world of engineering and construction and promises to unleash the potential of AI for simulation and advanced analytics in infrastructure digital twins.”
“Modern infrastructure are magnificent feats of engineering. NVIDIA and Bentley share a vision of physically based digital twins – so accurate and realistically simulated that they will revolutionize everything from infrastructure design to operations,” said Jensen Huang, founder and CEO of NVIDIA. “NVIDIA Omniverse was built precisely to realize this vision – to create shared virtual worlds that are simulated with physical and photo realism. We are delighted Bentley is developing applications for infrastructure digital twins on NVIDIA Omniverse.”
Unmatched High-Fidelity Infrastructure Visualization
The combination of the Bentley iTwin platform and NVIDIA Omniverse provides an unmatched, high-performance user experience at a scale that had previously not been possible.
The integration of the capabilities of the Bentley iTwin platform and NVIDIA Omniverse enables users to virtually explore massive industrial plants and offshore structures as if they are walking through the infrastructure in real time, for purposes such as wayfinding and safety route optimization.
“The industry is moving in a positive direction toward more automated and sophisticated tools that improve client outcomes,” said Donna DeMarco, plant information modeling, Jacobs. “Jacobs is proud to partner with Bentley in leveraging tools like iTwin linked with NVIDIA Omniverse to achieve strong results for our clients.”
Image and caption:
Houston Waterworks
Image courtesy of Houston Waterworks Team (a Joint Venture of Jacobs Engineering Group, Inc. and CDM Constructors, Inc.)
About NVIDIA Omniverse
NVIDIA Omniverse is an open platform for virtual collaboration and physically accurate simulation. Based on NVIDIA RTX technology, it leverages the Universal Scene Description (USD) common interchange format for real-time 3D visualization and simulation that was originally developed by Pixar to simplify entertainment industry workflows and is now being adopted in other industries including architecture, construction, and engineering, and digital factories.
About the Bentley iTwin Platform
The Bentley iTwin platform is an open, scalable cloud platform that enables project teams and owner-operators to create, visualize, and analyze digital twins of infrastructure assets. It enables digital information managers to incorporate engineering data created by diverse design tools into a living digital twin and align it with reality data, and other associated data with no disruption to their current tools or processes. Users are able to visualize and track changes including changes in real world conditions from IoT connected devices, such as sensors and drones. The Bentley iTwin platform facilitates actionable insights for decision makers across the organization and asset lifecycle. Users make better-informed decisions, anticipate and avoid issues before they arise, and react more quickly with confidence, resulting in cost savings, improved service availability, lower environmental impact, and improved safety. The Bentley iTwin platform is the foundation for applications ‘powered by iTwin’ and digital twin solutions created by Bentley and its strategic partners, digital integrators, system integrators, independent software vendors, and software developers.
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annualized revenues of more than $800 million in 172 countries. www.bentley.com
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, and ProjectWise are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005214/en/
Contact information
Press:
Christine Byrne
+1 203 805 0432
Christine.Byrne@bentley.com
Follow us on Twitter:
@BentleySystems
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom